Implantable cardioverter-defibrillators in cardiac amyloidosis: a grey zone requiring an individual approach
Kardiol Pol
.
2020 Sep 25;78(9):934-936.
doi: 10.33963/KP.15435.
Epub 2020 Jun 18.
Authors
Grzegorz Sławiński
1
,
Karolina Dorniak
2
,
Ewa Lewicka
3
Affiliations
1
Department of Cardiology and Electrotherapy, Medical University of Gdańsk, Gdańsk, Poland
2
Department of Noninvasive Cardiac Diagnostics, Medical University of Gdańsk, Gdańsk, Poland
3
Department of Cardiology and Electrotherapy, Medical University of Gdańsk, Gdańsk, Poland. elew@gumed.edu.pl
PMID:
32550732
DOI:
10.33963/KP.15435
No abstract available
MeSH terms
Amyloidosis*
Death, Sudden, Cardiac
Defibrillators, Implantable*
Humans